Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flagship Biotech International is a Mumbai-based pharmaceutical company specializing in the manufacturing, marketing, and global export of a broad range of pharmaceutical formulations. Established in 2008, the company has developed an extensive portfolio of over 700 products across various therapeutic segments including oncology, cardiology, gastroenterology, and infectious diseases. Flagship Biotech operates state-of-the-art manufacturing facilities in India that comply with global quality standards such as WHO-GMP and ISO certifications. The company has a significant international presence, exporting its generic medications and specialty injectables to more than 75 countries across Africa, Asia, CIS, and Latin America. Beyond its proprietary branded generics, it provides contract development and manufacturing (CDMO) services for a variety of dosage forms including solid orals, parenterals, and topical preparations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flagship Biotech.